Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

25 août 2020 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma and EVERSANA Announce the Appointment of Christopher Quesenberry as Chief Commercial Officer for Gimoti™

SOLANA BEACH, Calif. and CHICAGO, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases and...
06 août 2020 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Second Quarter 2020 Financial Results

SOLANA BEACH, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
15 juil. 2020 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Initiates Commercial Manufacturing of Gimoti™

SOLANA BEACH, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
08 juil. 2020 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Extends Cash Runway to 2Q 2021

SOLANA BEACH, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
19 juin 2020 15h32 HE | Source: Evoke Pharma, Inc.

FDA Approves Evoke’s GIMOTI™

Commercial Partner EVERSANA Prepares for GIMOTI LaunchEvoke Extends Cash Runway into 2021 SOLANA BEACH, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty...
20 mai 2020 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Receives FDA Conditional Acceptance of Gimoti Brand Name Following NDA Resubmission

SOLANA BEACH, Calif., May 20, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
12 mai 2020 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Reports First Quarter 2020 Financial Results and Changes its 2020 Annual Meeting of Stockholders to a Virtual Format

Gimoti™ Prescription Drug User Fee Act (PDUFA) date is June 19, 2020 SOLANA BEACH, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company...
12 mars 2020 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Fourth Quarter and Full Year 2019 Financial Results

SOLANA BEACH, Calif., March 12, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
27 janv. 2020 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Receives Notice of Allowance from USPTO for Gimoti™

SOLANA BEACH, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
23 janv. 2020 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Enters Commercialization Agreement with EVERSANA Life Sciences for Gimoti™

EVERSANA to commercialize and distribute Gimoti in the U.S. EVERSANA to provide $5 million revolving credit facility upon FDA approval SOLANA BEACH, Calif. and CHICAGO, Jan. 23, 2020 (GLOBE...

Page précédente